Oscar Health, INC Form 4 insider transactions
NYSE
Form 4: Oscar Health Executive Janet Liang Reports Acquisition of Restricted Stock Units and Stock Options
Janet Liang, President of Oscar Insurance, reports the acquisition of restricted stock units and stock options in Oscar Health, Inc.
NYSE
Director Sid Sankaran reports a gift of Oscar Health Class A Common Stock, both acquired and disposed of, on February 7, 2025.
NYSE
Oscar Health director Jeffery H. Boyd acquired 2,043 deferred stock units in lieu of cash compensation for board service.
NYSE
Alessandrea C. Quane, EVP and Chief Insurance Officer at Oscar Health, sold shares to cover tax obligations after restricted stock units vested.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, sold a portion of his Class A common stock after the vesting of restricted stock units.
NYSE
Form 4: Oscar Health COO Steven Wolin Executes Stock Transactions Following Vesting of Equity Awards
Oscar Health's Chief Operating Officer, Steven Wolin, engaged in multiple transactions involving Class A common stock, including the vesting of restricted stock units and subsequent sales to cover tax obligations.
NYSE
Oscar Health's President of Technology & CTO, Mario Schlosser, sold shares to cover tax obligations after restricted stock units vested.
NYSE
Ranmali Bopitiya, EVP & Chief Legal Officer at Oscar Health, sold shares to cover tax obligations following the vesting of restricted stock units.
NYSE
An Oscar Health executive, Alessandrea C. Quane, sold a portion of her Class A common stock after the vesting of restricted stock units, according to a recent SEC filing.
NYSE
Oscar Health's Chief Financial Officer, Richard Blackley, sold a portion of his Class A common stock following the vesting of restricted stock units.
NYSE
Oscar Health's Chief Accounting Officer, Victoria Baltrus, executed multiple transactions involving Class A common stock and restricted stock units, including sales to cover tax obligations.
NYSE
Thrive Capital, through its affiliated entities, has increased its holdings in Oscar Health by purchasing additional shares of Class A Common Stock.
NYSE
Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, has increased his indirect holdings through multiple purchases of Class A Common Stock.
NYSE
Elbert O. Robinson Jr., a director at Oscar Health, sold 25,000 shares of Class A Common Stock at an average price of $17.05 on November 20, 2024.
NYSE
Thrive Capital related entities have increased their holdings in Oscar Health through open market purchases of Class A Common Stock.
NYSE
Joshua Kushner, co-founder and vice chairman of Oscar Health, has increased his indirect holdings in the company through purchases made by Thrive Capital Partners VII Growth, L.P. and Claremount VII Associates, L.P.
NYSE
Oscar Health director Jeffery H. Boyd exercised stock options to acquire 577,027 shares of Class A Common Stock at $4.29 per share.
NYSE
Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, has increased his indirect holdings in the company through multiple purchases of Class A Common Stock between November 11th and November 13th, 2024.
NYSE
Thrive Capital, through various entities, has significantly increased its holdings in Oscar Health by purchasing shares over three consecutive days.
NYSE
Director Jeffery H. Boyd acquired 1,802 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.
NYSE
EVP and Chief Insurance Officer of Oscar Health, Alessandrea C. Quane, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
Richard Blackley, CFO of Oscar Health, Inc., sold 29,957 shares of Class A Common Stock at an average price of $17.06 on September 6, 2024, following the vesting of 62,500 restricted stock units on September 5, 2024.
NYSE
Richard Blackley, CFO of Oscar Health, reports the vesting of restricted stock units and subsequent sale of Class A Common Stock.
NYSE
Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., reports the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.
NYSE
Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, reports the vesting of restricted stock units and subsequent sale of Class A Common Stock to cover tax obligations.
NYSE
Steven Wolin, Chief Operating Officer of Oscar Health, Inc., reported the exercise of stock options and subsequent sale of Class A Common Stock to cover tax obligations.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, reported the vesting of restricted stock units and subsequent sales of Class A Common Stock to cover tax obligations.
NYSE
Alessandrea Quane, EVP and Chief Insurance Officer at Oscar Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
Jeffrey H. Boyd, a director at Oscar Health, Inc., acquired 1,883 deferred stock units in lieu of cash retainer payments for board service on July 11, 2024.
NYSE
Director Elbert O. Robinson Jr. acquired 8,974 shares of Oscar Health, Inc. Class A common stock through restricted stock units on June 6, 2024.